Consolidated Statements of Changes in Stockholders' Equity - USD ($) $ in Thousands	Total	Common Stock	Additional Paid-in Capital	Retained Earnings	Accumulated Other Comprehensive Income
Beginning balance (in shares) at Dec. 31, 2022		72,585,596
Beginning balance at Dec. 31, 2022	$ 3,091,784	$ 726	$ 1,784,173	$ 1,306,885	$ 0
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income	80,700			80,700
Other comprehensive income (loss)	323				323
Shares issued under stock-based compensation programs, net (in shares)		503,022
Shares issued under stock-based compensation programs, net	(11,740)	$ 5	(11,745)
Cash dividends declared	(36,543)			(36,543)
Stock-based compensation expense	5,597		5,597
Forfeiture of restricted stock (in shares)		(1,283)
Forfeiture of restricted stock	0
Ending balance (in shares) at Mar. 31, 2023		73,087,335
Ending balance at Mar. 31, 2023	$ 3,130,121	$ 731	1,778,025	1,351,042	323
Beginning balance (in shares) at Dec. 31, 2023	74,661,479	74,661,479
Beginning balance at Dec. 31, 2023	$ 3,377,885	$ 747	1,824,434	1,552,653	51
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income	95,819			95,819
Other comprehensive income (loss)	(47)				(47)
Shares issued under stock-based compensation programs, net (in shares)		386,523
Shares issued under stock-based compensation programs, net	(25,626)	$ 3	(25,629)
Cash dividends declared	(41,276)			(41,276)
Stock-based compensation expense	2,632		2,632
Forfeiture of restricted stock (in shares)		(301)
Forfeiture of restricted stock	$ 0
Ending balance (in shares) at Mar. 31, 2024	75,047,701	75,047,701
Ending balance at Mar. 31, 2024	$ 3,409,387	$ 750	$ 1,801,437	$ 1,607,196	$ 4